Targeting YTHDF1 (a reader) might be another promising therapeutic approach, as (Liu et al., 2020) identified the YTHDF1-EIF3C axis as a critical translational factor involved in ovarian cancer progression (Liu et al., 2020). The gene discussed is YTHDF1; the disease is ovarian cancer.